IMPACT HTA Issues Recommendations on RWE in Decision-Making, Highlights Transparency

IMPACT Health Technology Assessment (HTA) has issued a series of recommendations intended to inform decision-makers using real world evidence (RWE). The guidelines address existing challenges and gaps ahead of recommendations issued by the Food and Drug Administration and the UK’s National Institute for Health and Care Excellence. The recommendations emphasize data transparency and interoperability.

“We believe these recommendations are a preview of what to expect from future regulator and HTA guidance on RWE. A similar focus on principled database epidemiology (e.g., specific recommendations on study design strategies, adjusting for confounding, and sensitivity analysis) and transparency are likely to follow from decision makers.” Read more here.

(Source: Ashley Jaksa, Aetion, 8/5/21)